Revenue

The Chinese robotics firm posted record revenue but a staggering $5.6M loss. Is this a strategic masterstroke or a reckless bet on a future that may never pay off?

Fortress Biotech's Q2 net loss masks a cash-rich strategy. A $117M cash surge and major pipeline wins reveal a model built for the long haul.

Intellicheck posts record Q2 revenue and a fifth straight profitable quarter, but a key client's pivot to a multi-vendor model tests its diversification strategy.

dLocal posts a stunning 92% surge in payment volume, cementing its emerging market dominance. Yet, a closer look at profitability reveals a complex balancing act.

Don't let headline numbers fool you. True North's Q2 reveals a 7.1% NOI surge and 96% occupancy, a testament to its sharp portfolio management.

Plunging revenues and a staggering net loss push IM Cannabis to the edge, forcing a desperate and bizarre strategic pivot from medical marijuana to military drones.

Kyntra Bio's Q2 profit was driven by a one-time accounting gain, masking operating losses. Now, the firm bets its future on two critical Q4 data readouts.

Soluna Holdings reports a 145% revenue surge but a widening net loss, revealing a bold strategy to trade short-term profits for a vast green AI infrastructure.

With a $115M financing and an expanded pipeline, Assembly Biosciences is betting on novel therapies for liver and viral diseases. But can it navigate a crowded field?

The InsurTech firm posted a Q2 loss and falling revenue, but its forward-looking metrics tell a different story. A deep dive into a high-stakes bet on AI.

As Toronto prepares a final salute to the Snowbirds, their grounding reveals a strategic military shift and a major air show's plan for reinvention.

With mounting losses and a CEO's unyielding optimism, activist investors issue an ultimatum: take proteomics firm Seer private or face the consequences.

Amid rising costs, Trust Stamp pivots to the $48B Sovereign-AI market and a key EU semiconductor project, signaling a strategic shift to national tech security.

While many companies chase rapid expansion, Go Mini's is quietly building an empire by empowering its best franchisees. This is a look at their 'quality over speed' playbook.

A semiconductor firm is merging with a critical minerals miner. This isn't just M&A; it's a radical bet on vertical integration. We dig into the strategy.

Saga Communications reports falling revenues and operating losses, yet its digital arm surges. A deep dive into the broadcaster's high-stakes balancing act.

With a new CRO and a 'historic' growth year, Auvik is betting on Daniel Ochoa's channel expertise to scale its AI platform in a crowded market.

With strong Q2 results as a tailwind, Interlink is making a bold move with a transformative acquisition and new sensor tech. But can it execute?

Orbit International's Q2 report shows deepening losses from contract delays, but a rising backlog and stronger margins in key divisions suggest a complex path to recovery.

While many retailers retreat, INDOCHINO is doubling down on physical stores. A deep dive into the financial and strategic bet on a new kind of showroom.